Top News
Osimertinib-Associated Cardiac Toxicity: A Retrospective Study
Low-Dose Aspirin Reduced Risk of HCC in Patients With HBV or HCV
Selumetinib Deemed Effective in Pediatric Inoperable Plexiform Neurofibromas
Persistent Leukocytosis as a Marker for Disease Progression in Polycythemia Vera
FDA: All Ranitidine Products Must Be Removed From the Market
Postsurgical Mutations Detected in Cell-Free DNA in Endometrial Cancer May Indicate Poor Prognosis
Potential Predictors of Cell Transformation in Normal Fallopian Tubes of Women With a Deleterious BRCA1 Mutation
Real-World Data Show Low Rates of Somatic BRCA Mutation Testing in Ovarian Cancer
Learning Curve Associated With Minimally Invasive Radical Hysterectomy May Be Steep, Study Finds
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
High Response Rates to CAR-T Seen in Mantle Cell Lymphoma
In the phase 2 ZUMA-2 study, KTE-X19 CAR-T therapy showed a lasting clinical benefit and manageable side effects in relapsed/refractory mantle cell lymphoma. -
SGO 2020 Coverage
News coverage from the Society of Gynecologic Oncology 2020 meeting. -
CAR-T in ALL: Records Reveal Direct Costs for Hospitalization Approach $300K
The median total cost of hospitalization resulting from CAR-T treatment was found to be $380,052, with a median direct cost of $262,981. -
Is Neoadjuvant Chemotherapy in Malignant Pleural Mesothelioma Beneficial?
Neoadjuvant chemotherapy was found to negatively impact survival in resectable malignant pleural mesothelioma. -
CAR-NK Cells Make Their Debut in Hematologic Cancers
The new type of adoptive cell therapy showed a response in 8 of 11 patients with hematologic malignancies in a clinical study. -
Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing. -
Large Consortium Study Reveals More Details on the Link Between Viruses and Cancer
Researchers use whole-genome and whole-transcriptome sequencing data to reveal viral sequences in cancer tissue.
More Features
COVID-19 Pandemic Delaying Treatments of Hematologic Cancers
Some US medical centers have canceled treatments and all centers have altered their policies and procedures out of precaution related to the COVID-19 pandemic.
Chronic Lymphocytic Leukemia Treatment Decision Making With Venetoclax-Based Therapy
A review of case studies that outline treatment decisions based on patient and disease characteristics.
Prostate MRI Improves Confirmatory Biopsy Sensitivity
MRI-guided confirmatory prostate biopsies more accurately detects grade progression among men on active surveillance for prostate cancer compared with TRUS-guided systematic biopsies alone.
Salvage Radiotherapy Called a Viable Option for Recurrent Prostate Cancer
The authors of new review say the results of the JCOG0401 trial suggest that standard hormonal therapy alone vs salvage radiotherapy is not an appropriate management strategy for recurrence after radical prostatectomy.
Breast Cancer in Women vs Men: Prolonged Survival in Women May Be Influenced by Lead-Time Bias
Recent studies suggest that some misunderstanding around lead-time bias continues to persist in the literature.
